Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Goldman likes Haleon but says sell Schroders

Wed, 20th Jul 2022 09:41

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

----------

FTSE 100

----------

DZ Bank raises fair value for GSK to 1,850 (1,800) pence - 'hold'

----------

Goldman Sachs starts Haleon with 'buy' - price target 350 pence

----------

JPMorgan starts Haleon with 'underweight' - price target 280 pence

----------

UBS starts Haleon with 'buy' - price target 380 pence

----------

Bank of America starts Haleon with 'buy' - price target 385 pence

----------

Berenberg raises Informa price target to 700 (685) pence - 'buy'

----------

Bank of America raises Informa price target to 780 (740) pence - 'buy'

----------

Goldman Sachs cuts Entain price target to 1,975 (2,100) pence - 'buy'

----------

Berenberg cuts Entain price target to 1,950 (2,060) pence - 'buy'

----------

Goldman Sachs cuts Flutter price target to 13,400 (14,900) pence - 'buy'

----------

Jefferies raises Burberry price target to 1,880 (1,750) pence - 'hold'

----------

Morgan Stanley raises Pearson price target to 800 (750) pence - 'equal-weight'

----------

Morgan Stanley raises Relx price target to 2,860 (2,750) pence - 'overweight'

----------

UBS cuts WPP price target to 1,225 (1,500) pence - 'buy'

----------

Citigroup cuts Hargreaves Lansdown price target to 890 (1,000) pence - 'neutral'

----------

Goldman Sachs starts abrdn with 'neutral' - price target 180 pence

----------

Goldman Sachs starts Schroders with 'sell' - price target 2,530 pence

----------

Barclays cuts Prudential price target to 1,500 (1,665) pence - 'overweight'

----------

Barclays raises M&G price target to 226 (195) pence - 'underweight'

----------

Barclays cuts Legal & General price target to 380 (400) pence - 'overweight'

----------

Barclays cuts Aviva price target to 553 (620) pence - 'equal weight'

----------

Barclays cuts Admiral price target to 2,583 (3,050) pence - 'overweight'

----------

JPMorgan cuts Antofagasta price target to 1,460 (1,480) pence - 'neutral'

----------

Goldman Sachs raises Rio Tinto price target to 5,700 (5,680) pence - 'buy'

----------

HSBC cuts Shell price target to 2,550 (2,700) pence - 'buy'

----------

HSBC cuts BP price target to 430 (455) pence - 'hold'

----------

Barclays cuts Spirax-Sarco price target to 11,150 (13,590) pence - 'equal weight'

----------

FTSE 250

----------

Citigroup cuts Derwent London price target to 2,506 (2,667) pence - 'sell'

----------

Morgan Stanley cuts ITV price target to 65 (110) pence - 'equal-weight'

----------

UBS cuts ITV price target to 135 (155) pence - 'buy'

----------

Morgan Stanley cuts Ascential target to 330 (425) pence - 'equal-weight'

----------

Barclays cuts Ascential price target to 390 (430) pence - 'overweight'

----------

Berenberg cuts 888 Holdings price target to 370 (500) pence - 'buy'

----------

Jefferies reinitiates Playtech with 'buy' - price target 550 pence

----------

Barclays cuts Just Group price target to 120 (125) pence - 'overweight'

----------

Barclays cuts IntegraFin price target to 370 (380) pence - 'overweight'

----------

RBC cuts IntegraFin price target to 330 (380) pence - 'sector perform'

----------

Goldman Sachs starts Man Group with 'buy' - price target 315 pence

----------

JPMorgan cuts Direct Line price target to 230 (240) pence - 'neutral'

----------

Barclays cuts Direct Line price target to 292 (323) pence - 'equal weight'

----------

HSBC cuts Direct Line to 'reduce' (hold) - price target 175 (285) pence

----------

Berenberg cuts Lancashire price target to 700 (760) pence - 'buy'

----------

Citigroup cuts Quilter to 'neutral' (buy) - price target 105 (170) pence

----------

Barclays cuts Rotork price target to 310 (345) pence - 'overweight'

----------

Barclays cuts Bodycote price target to 595 (695) pence - 'equal weight'

----------

HSBC raises Victrex price target to 2,000 (1,900) pence - 'hold'

----------

Barclays cuts Vesuvius price target to 310 (375) pence - 'underweight'

----------

Barclays cuts Renishaw price target to 3975 (4200) pence - 'underweight'

----------

RBC cuts Hochschild Mining price target to 130 (140) pence - 'outperform'

----------

JPMorgan cuts Elementis price target to 144 (155) pence - 'neutral'

----------

Bernstein starts Aston Martin with 'market-perform' - price target 460 pence

----------

Kepler Cheuvreux raises Aston Martin price target to 400 (350) pence - 'reduce'

----------

JPMorgan raises Babcock International target to 500 (480) pence - 'overweight'

----------

SMALL CAP

----------

UBS cuts BHP price target to 2,050 (2,100) pence - 'neutral'

----------

JPMorgan cuts BHP price target to 2,440 (2,510) pence - 'neutral'

----------

Berenberg cuts Petra Diamonds price target to 107 (129) pence - 'hold'

----------

Morgan Stanley cuts S4 Capital price target to 700 (725) pence - 'overweight'

----------

Citigroup cuts Just Eat Takeaway.com price target to 37 (98) EUR - 'buy'

----------

Citigroup cuts Deliveroo price target to 110 (200) pence - 'buy'

----------

Goldman Sachs cuts Deliveroo price target to 145 (160) pence - 'buy'

----------

SocGen raises Fevertree to 'hold' (sell) - price target 900 (1,550) pence

----------

JPMorgan cuts Trustpilot price target to 110 (135) pence - 'neutral'

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.